surmount trial tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the -OSA phase 3 surmount-1 tirzepatide non-diabetic obesity trial
Pay in 4 interest-free payments of $5.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3





























